Development of a disposable hollow fibre-solid phase microextraction device using chitosan functionalised MWCNTs and a polyoxometalate for the simultaneous extraction of angiotensin II receptor blocker drugs
{"title":"Development of a disposable hollow fibre-solid phase microextraction device using chitosan functionalised MWCNTs and a polyoxometalate for the simultaneous extraction of angiotensin II receptor blocker drugs","authors":"Aref Ansari Mohseni, Mahmoud Ebrahimi, Safarali Beyramabadi","doi":"10.1080/03067319.2023.2253736","DOIUrl":null,"url":null,"abstract":"ABSTRACTValsartan and Losartan are two angiotensin II receptor blocker drugs used to treat heart failure and high blood pressure. A straightforward and disposable hollow fibre-solid phase microextraction device was developed to extract these drugs from real water and urine samples. A green sorbent was synthesised by functionalised MWCNTs with chitosan through a chemical route method. Besides, a polyoxometalate (Ni-CoWO4 nanoparticles) was prepared as a modifier using the hydrothermal procedure. Using the sol-gel strategy, the sorbent and modifier were reinforced in the hollow fibre pores and lumen. The approach leads to an increase in the sorbent coating stability on/in hollow fibre. The influential factors were optimised with an experimental design, indicating that pH, extraction time, and desorption time significantly affect the Valsartan and Losartan extraction. The linearity of the method to determine Valsartan and Losartan was 3.4–1850 and 3.1–1800 ng mL−1, with R squared of 0.9929 and 0.9947, respectively. The detection and quantification limits were lower than 0.9 ng mL−1 and 3.4 ng mL−1, respectively. The pre-concentration factors for determining Valsartan and Losartan with a concentration of 20 ng mL−1 were 654.2 and 546.3, respectively. The intra-day and inter-day RSDs were lower than 3.11% and 3.87% for measuring Valsartan and Losartan. The recoveries and RSDs for analysing spiked eal water and urine samples were between 91.8–97.8% and 3.16–4.10%, respectively.KEYWORDS: ValsartanLosartanhollow fibre-solid phase microextractionMWCNTsPolyoxometalateschitosan AcknowledgmentsThe authors express their appreciation to the Research Council of Islamic Azad University of Mashhad, Iran, for financial support.Disclosure statementThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Compliance with ethical standardsThe study has been carried out under the institutional and/or national research committee’s ethical standards and with the 1964 Helsinki declaration and its later amendments or comparable. Ethical standards.CRediT authorship contribution statementAref Ansari Mohseni: Conceptualization, Writing e original draft, Investigation, Methodology, Data curation, Formal analysis, Resources.Mahmoud Ebrahimi: Supervisor, Investigation, Writing e review & editing.Safarali Beyramabadi: Advisor, Investigation, Writing e review & editing.Supplementary dataSupplemental data for this article can be accessed online at https://doi.org/10.1080/03067319.2023.2253736.","PeriodicalId":13973,"journal":{"name":"International Journal of Environmental Analytical Chemistry","volume":"21 1","pages":"0"},"PeriodicalIF":2.3000,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Environmental Analytical Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/03067319.2023.2253736","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
ABSTRACTValsartan and Losartan are two angiotensin II receptor blocker drugs used to treat heart failure and high blood pressure. A straightforward and disposable hollow fibre-solid phase microextraction device was developed to extract these drugs from real water and urine samples. A green sorbent was synthesised by functionalised MWCNTs with chitosan through a chemical route method. Besides, a polyoxometalate (Ni-CoWO4 nanoparticles) was prepared as a modifier using the hydrothermal procedure. Using the sol-gel strategy, the sorbent and modifier were reinforced in the hollow fibre pores and lumen. The approach leads to an increase in the sorbent coating stability on/in hollow fibre. The influential factors were optimised with an experimental design, indicating that pH, extraction time, and desorption time significantly affect the Valsartan and Losartan extraction. The linearity of the method to determine Valsartan and Losartan was 3.4–1850 and 3.1–1800 ng mL−1, with R squared of 0.9929 and 0.9947, respectively. The detection and quantification limits were lower than 0.9 ng mL−1 and 3.4 ng mL−1, respectively. The pre-concentration factors for determining Valsartan and Losartan with a concentration of 20 ng mL−1 were 654.2 and 546.3, respectively. The intra-day and inter-day RSDs were lower than 3.11% and 3.87% for measuring Valsartan and Losartan. The recoveries and RSDs for analysing spiked eal water and urine samples were between 91.8–97.8% and 3.16–4.10%, respectively.KEYWORDS: ValsartanLosartanhollow fibre-solid phase microextractionMWCNTsPolyoxometalateschitosan AcknowledgmentsThe authors express their appreciation to the Research Council of Islamic Azad University of Mashhad, Iran, for financial support.Disclosure statementThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Compliance with ethical standardsThe study has been carried out under the institutional and/or national research committee’s ethical standards and with the 1964 Helsinki declaration and its later amendments or comparable. Ethical standards.CRediT authorship contribution statementAref Ansari Mohseni: Conceptualization, Writing e original draft, Investigation, Methodology, Data curation, Formal analysis, Resources.Mahmoud Ebrahimi: Supervisor, Investigation, Writing e review & editing.Safarali Beyramabadi: Advisor, Investigation, Writing e review & editing.Supplementary dataSupplemental data for this article can be accessed online at https://doi.org/10.1080/03067319.2023.2253736.
期刊介绍:
International Journal of Environmental Analytical Chemistry comprises original research on all aspects of analytical work related to environmental problems. This includes analysis of organic, inorganic and radioactive pollutants in air, water, sediments and biota; and determination of harmful substances, including analytical methods for the investigation of chemical or metabolic breakdown patterns in the environment and in biological samples.
The journal also covers the development of new analytical methods or improvement of existing ones useful for the control and investigation of pollutants or trace amounts of naturally occurring active chemicals in all environmental compartments. Development, modification and automation of instruments and techniques with potential in environment sciences are also part of the journal.
Case studies are also considered, particularly for areas where information is scarce or lacking, providing that reported data is significant and representative, either spatially or temporally, and quality assured. Owing to the interdisciplinary nature of this journal, it will also include topics of interest to researchers in the fields of medical science (health sciences), toxicology, forensic sciences, oceanography, food sciences, biological sciences and other fields that, in one way or another, contribute to the knowledge of our environment and have to make use of analytical chemistry for this purpose.